Interestingly, since the expression of CCR4 is higher in Tregs than other CD4+ T cells, probably because of a FOXP3 responsive element on the CCR4 promoter [265], Tregs infiltration is favored in some tumors, e.g., in breast cancer [241]. The gene discussed is FOXP3; the disease is breast cancer.